thymidine

We are thymidine CAS:50-89-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:thymidine
CAS.NO:50-89-5
Synonyms:THYMIDINE
2,4(1H,3H)-Pyrimidinedione,1-(2-deoxy-Beta-D-erythro-pentofuranosyl)-5-methyl
2'-dT
2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-β-D-erythro-pentofuranosyl)-5-methyl
Molecular Formula:C10H14N2O5
Molecular Weight:242.22900
 
Physical and Chemical Properties:
Density:1.452
Melting point:187-189ºC
Index of Refraction:1.584
 
Specification:
Appearance:White to off-white crystalline powder
Assay(HPLC):≥99.0%
Loss on drying:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Zidovudine.

thymidine


Related News: Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.butano-2,3-diona CAS:431-03-8 Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs. PIRIDINA DE 2-METIL-5-HIDROXIA CAS:1121-78-4 The main API products include antihypertensive, psychotropic and anti-AIDS special APIs. Antihypertensive APIs are mainly pulic and sartan drugs, and they are the world’s major suppliers of pulic and sartan APIs.598-65-2 It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.

Related Products
Product Name
(2S)-2-amino-3-(4-nitrophenyl)propanoic acid,hydrate View Details
N-Carbobenzyloxy-L-valine View Details
Bis(2,6-difluoro-3-(1-hydropyrrol-1-yl)phenyl)titanocene View Details
ethyl 3-chlorosulfonyl-1-methylpyrazole-4-carboxylate manufacturer [(2S)-1-acetamido-3-chloropropan-2-yl] acetate manufacturer (R,E)-5-([1,1′-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid manufacturer 5-Fluoro-2-methylbenzonitrile manufacturer (Chloromethyl)triethoxysilane manufacturer